Results 221 to 230 of about 6,168,048 (271)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Multivitamin supplements are not superior to nutrition education in improving fat-soluble vitamin levels: A double-blind randomized controlled trial. [PDF]

Asia Pac J Clin Nutr
Yusupu S, Yang Y, Geng X, Lin Z, Sun T, Wang Z, Lu H, Deng Y.   +7 more
europepmc   +1 more source

УÑÐµÑ Ð¸ анализ ÑаÑÑеÑов по Ð½Ð°Ð»Ð¾Ð³Ñ Ð½Ð° пÑибÑÐ»Ñ Ð² коммеÑÑеÑÐºÐ¸Ñ Ð¾ÑганизаÑиÑÑ

, 2017
Анна Молчанова
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Formal Synthesis of Ortho-Cyanated N-Heterocycles via Direct, Metal-Free Cyanation of N-Oxides Under Benign Conditions. [PDF]

Molecules
Xiao H, Wufuer R, Wang D.
europepmc   +1 more source

ÐÑкÑÐ²Ð°Ð½Ð½Ñ Ñ Ð¿ÑоÑÑлакÑика гнÑйно-ÑепÑиÑÐ½Ð¸Ñ ÑÑÐºÐ»Ð°Ð´Ð½ÐµÐ½Ñ Ñа ÑÑоÑепÑиÑÑ Ð¿ÑÑÐ»Ñ Ð´Ð¸ÑÑанÑÑÐ¹Ð½Ð¾Ñ Ð»ÑÑоÑÑипÑÑÑ.

, 2013
С. І. Баранник, І. Д. Крижановський, І. Б. Білий, А. С. Бараннік   +3 more
openalex   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

A transpupillary approach for crosslinking Guinea pig sclera using WST11 and near-infrared light. [PDF]

Sci Rep
Vogels DHJ, Abdulla Y, Myles W, Cummings S, Agemy L, Yechezkel T, Marcovich AL, Scherz A, LaPointe VLS, McFadden SA, Dickman MM.   +10 more
europepmc   +1 more source

ÐÑинÑипи лÑкÑвалÑÐ½Ð¾Ñ ÑакÑики пÑи гоÑÑÑо-кÑовоÑоÑÐ¸Ð²Ð¸Ñ Ð·Ð»Ð¾ÑкÑÑÐ½Ð¸Ñ Ð¿ÑÑÐ»Ð¸Ð½Ð°Ñ ÑлÑнка

, 2015
П. В. Іванчов
openalex   +2 more sources